Trending...
- Connected Technologies Delivers Cutting-Edge Technology to Landmark Properties' Student Housing Communities
- The Power Of Online Reviews & Why They Matter
- Craft Holsters Unveils Comprehensive SIG Sauer Guides for Firearm Enthusiasts
ESTERO, Fla. - iSportsWire -- Southwest Florida Proton has hired Dr. Shannon MacDonald, an international leader and pioneer in the field of proton therapy, to serve as the new center's senior medical director.
In this role, MacDonald will work alongside Dr. Arie Dosoretz, managing partner, and Dr. Todd Pezzi, associate medical director, to oversee the center's clinical operations and guide long-term strategic planning. MacDonald's clinical expertise is treating breast, pediatric, skull-base tumors and sarcomas.
"The team that envisioned and developed Southwest Florida Proton recognizes the future of cancer care is moving toward proton therapy as a preferred course of treatment for many types of cancers," MacDonald said. "After committing my 18-year career to proton therapy treatment, it's exciting to be part of this evolution and introduce this state-of-the-art proton therapy as an option for cancer patients seeking this care in Southwest Florida."
More on iSports Wire
Proton therapy, which uses charged proton particles accelerated to two-thirds the speed of light to destroy cancer cells, is an effective treatment option for cancers of the brain and spine, breast, esophagus, head and neck, liver, lung, eye, pancreas, prostate, lymphoma and sarcomas. Research shows it's a safe option for patients who have undergone prior radiation treatment when regular radiation is not an option. Many studies have shown reduced long-term radiation risks, such as growth impairment and learning disabilities in pediatric cancer patients. In adult sarcomas, protons can achieve higher doses of tumors than traditional radiation, allowing for the cure of these sarcomas that were not possible or safe with regular radiation. Protons are particles that travel into a cancer, but not beyond it, which avoids the risks of radiation damage in organs that do not have cancer cells. Regular radiation must enter and exit, leading to more collateral damage in healthy tissues.
More on iSports Wire
Prior to joining Southwest Florida Proton, MacDonald was an accomplished associate professor of radiation oncology at Harvard Medical School while also serving as director of base-of-skull service, director of sarcoma service and proton therapy liaison at Massachusetts General Hospital to provide this therapy for patients at Dana Farber Cancer Institute and Boston Children's Hospital, where she was also credentialed to see patients. Her previous roles at Mass General included director of breast radiation oncology, course director for radiation oncology and Harvard Medical School student clinical clerkship. She has served on leadership committees for various international, national, regional and local organizations, including the National Accreditation Program for Breast Centers, Children's Oncology Group and the Particle Therapy Cooperative Group. She has run numerous trials for proton radiation and is the clinical chair of RADCOMP, the most prominent randomized trial studying proton therapy for breast cancer.
For more information, please visit SWFLproton.com.
In this role, MacDonald will work alongside Dr. Arie Dosoretz, managing partner, and Dr. Todd Pezzi, associate medical director, to oversee the center's clinical operations and guide long-term strategic planning. MacDonald's clinical expertise is treating breast, pediatric, skull-base tumors and sarcomas.
"The team that envisioned and developed Southwest Florida Proton recognizes the future of cancer care is moving toward proton therapy as a preferred course of treatment for many types of cancers," MacDonald said. "After committing my 18-year career to proton therapy treatment, it's exciting to be part of this evolution and introduce this state-of-the-art proton therapy as an option for cancer patients seeking this care in Southwest Florida."
More on iSports Wire
- The Dallas Group of America, Inc. Celebrates the 50th Anniversary of Landmark Facility
- Sarasota Paradise set to face off against FC Naples in 2025 Lamar Hunt U.S. Open Cup
- Keeperstop.com Unveils Go-To Resource for Goalkeeper Gloves
- Kelvin Emtech and Colm Engineering Unveil Strategic Joint Venture, to Boost Data Center and Building M&E Capabilities
- Citizens for West Virginia Election Integrity Calls for Urgent Reforms to Safeguard State Elections
Proton therapy, which uses charged proton particles accelerated to two-thirds the speed of light to destroy cancer cells, is an effective treatment option for cancers of the brain and spine, breast, esophagus, head and neck, liver, lung, eye, pancreas, prostate, lymphoma and sarcomas. Research shows it's a safe option for patients who have undergone prior radiation treatment when regular radiation is not an option. Many studies have shown reduced long-term radiation risks, such as growth impairment and learning disabilities in pediatric cancer patients. In adult sarcomas, protons can achieve higher doses of tumors than traditional radiation, allowing for the cure of these sarcomas that were not possible or safe with regular radiation. Protons are particles that travel into a cancer, but not beyond it, which avoids the risks of radiation damage in organs that do not have cancer cells. Regular radiation must enter and exit, leading to more collateral damage in healthy tissues.
More on iSports Wire
- Patton Launches SFP-based RS-232/422/485 Serial Device Server
- Local Tech Entrepreneur Partners with WonderSouq To Offer Downtown Medford Businesses a Virtual City Experience
- Boston Bridal Atelier Enhances Luxury Experience with New Bridal Shop Location
- New Website for Solo Agers Over 50
- Malcolm-Jamal Warner Returns to Columbia for an Unforgettable Evening of Poetry & Music
Prior to joining Southwest Florida Proton, MacDonald was an accomplished associate professor of radiation oncology at Harvard Medical School while also serving as director of base-of-skull service, director of sarcoma service and proton therapy liaison at Massachusetts General Hospital to provide this therapy for patients at Dana Farber Cancer Institute and Boston Children's Hospital, where she was also credentialed to see patients. Her previous roles at Mass General included director of breast radiation oncology, course director for radiation oncology and Harvard Medical School student clinical clerkship. She has served on leadership committees for various international, national, regional and local organizations, including the National Accreditation Program for Breast Centers, Children's Oncology Group and the Particle Therapy Cooperative Group. She has run numerous trials for proton radiation and is the clinical chair of RADCOMP, the most prominent randomized trial studying proton therapy for breast cancer.
For more information, please visit SWFLproton.com.
Source: Southwest Florida Proton
0 Comments
Latest on iSports Wire
- Discover the Culinary Heart of Le Marche: A 5-Night Food & Wine Tour + Farm to Table Cooking Classes in Italy's Hidden Gem
- The One Experience™, Inc. Announces Presenting Sponsors and Partners for Flagship Event
- Introducing HOME-OMETRY, the Social Media Network for Real Estate
- International Martial Arts Association Explains the Meaning of "Do"
- Sarasota Paradise to compete in Lamar Hunt U.S. Open Cup
- Italian iGaming Landscape Expands with Notable Merger: Gaming Report Acquires Gaming Insider
- Retrospec Appoints Nick Marvik as New Head of Growth to Lead eCommerce Expansion
- Battlefield FCA Announces Two Prestigious Academic Scholarships for Local High School Seniors
- What's Next for College Athletes After the College Football Championship?
- USMNT player and local soccer legend Tyler Adams to Join Westchester SC Ownership Group
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Advanced HDR by Technicolor Enables 2024 UEFA Championship's French Broadcast in High Dynamic Range
- ®Grammy Award Winner Alex Cuba releases new single "El Día Más Triste"
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
- LAIIER Closes Oversubscribed US$4M Seed Extension Funding Round, Led by Closed Loop Partners
- Deep Learning Robotics (DLRob) Secures European Patent Office Approval for Revolutionary Robot Learning Technology
- Turbocharge Small- and Medium-Size Business Financing with Faster Funding's Innovative Business Credit Building and Financing Suite
- Inframark's Oklahoma City Team Wins OWEA Awards, Exemplary Employer Accolade
- Hitachi Construction Machinery estabelece sede regional na América Latina no Chile
- Hitachi Construction Machinery establece su sede regional para América Latina en Chile